P. Challita-Eid

发表

Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.

S. Kanner, A. Raitano, Z. An, 2007, Cancer research.

Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody-Drug Conjugates.

R. Hubert, D. Stover, S. Karki, 2018, Cancer research.

Discoidin Domain Receptor 1 Contributes to Tumorigenesis through Modulation of TGFBI Expression

D. Stover, Z. An, Mi-Sook Chang, 2014, PloS one.

Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors.

M. Halterman, H. Federoff, V. Planelles, 1999, Blood.

AGS 16 F Is a Novel Antibody Drug Conjugate Directed against ENPP 3 for the Treatment of Renal Cell Carcinoma

D. Stover, S. Karki, A. Raitano, 2016 .

AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma

D. Stover, S. Karki, A. Raitano, 2015, Clinical Cancer Research.

Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein.

V. Planelles, B. Rimel, J. Rosenblatt, 1998, AIDS research and human retroviruses.

A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway.

S. Morrison, M. Penichet, D. Slamon, 1998, Journal of immunology.

T Cell Costimulatory Pathway Antibody Specificity and Ability to Activate Via A B 7 . 1-Antibody Fusion Protein

S. Morrison, M. Penichet, D. Slamon, 1998 .

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

J. Dick, T. Kipps, D. Stover, 2015, Molecular Cancer Therapeutics.

Inhibition of HIV-1 Replication Using a Mutated tRNALys-3 Primer*

R. Bambara, D. Kohn, V. Planelles, 1997, The Journal of Biological Chemistry.

The Discovery and Preclinical Development of ASG-5ME, an Antibody–Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer

D. Stover, A. Raitano, Z. An, 2016, Molecular Cancer Therapeutics.

Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models.

D. Stover, S. Karki, A. Raitano, 2016, Cancer research.

Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics.

D. Stover, Z. An, Mi-Sook Chang, 2013, Neoplasia.

Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker

D. Stover, A. Raitano, Z. An, 2016, Molecular Cancer Therapeutics.

Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti‐tumor CTL and TH1 cytokine responses by B cells

A. Divekar, B. Segal, J. Rosenblatt, 2005, International journal of cancer.

A murine B cell lymphoma expressing human HER2/neu undergoes spontaneous tumor regression and elicits antitumor immunity

S. Morrison, M. Penichet, J. Rosenblatt, 2001, Cancer Immunology, Immunotherapy.

A RANTES-antibody fusion protein retains antigen specificity and chemokine function.

S. Morrison, M. Penichet, C. Abboud, 1998, Journal of immunology.

Antigen Specificity and Chemokine Function A RANTES-Antibody Fusion Protein

S. Morrison, M. Penichet, C. Abboud, 1998 .

Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker

D. Stover, A. Raitano, Z. An, 2016, Molecular Cancer Therapeutics.

Inhibition of HIV-1 Replication Using a Mutated tRNA Primer*

R. Bambara, D. Kohn, V. Planelles, 1997 .

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

J. Dick, T. Kipps, D. Stover, 2015, Molecular Cancer Therapeutics.